Astellas has made three senior-level promotions within its development organization. Joseph Fleishaker, Ph.D., FAAPS, FCP, was promoted to senior vice president and head of Clinical Pharmacology and Exploratory Development (CPED); Susanne Gronen was promoted to senior vice president and head of Data Sciences; and, Andrew Krivoshik, M.D., Ph.D., was promoted to vice president of Medical Science, Oncology. 
 
Dr. Fleishaker will report to Dr. Zeiher and will be responsible for providing leadership of the clinical pharmacology and early development work across the global development portfolio. Ms. Gronen will also report to Dr. Zeiher and provide global leadership of the Data Sciences function, which includes biostatistics, data management, medical writing, statistical programming, and systems management.

Dr. Krivoshik will report to Steven Benner, M.D., senior vice president and Therapeutic Area Head for Oncology. He will lead the medical group within Oncology, responsible for helping to advance Astellas’ oncology pipeline, which includes numerous clinical programs in areas such as prostate cancer, leukemia, lung cancer, bladder cancer, breast cancer, and gastroesophageal adenocarcinoma, among others.
 
“These promotions reinforce the strength of talent we have across the development organization at Astellas,” said Bernhardt G. Zeiher, M.D., president, Development, Astellas. “I couldn’t be more pleased that Joe, Susanne and Andrew will be leading critical parts of our global organization so we can deliver valuable medicines to patients.”